Rigid Bronchoscopy with Laser and Stent Placement for Bronchus Intermedius Obstruction from Lung Cancer Involving the Right Main Pulmonary Artery

Published on 23/05/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 23/05/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 3015 times

Chapter 22 Rigid Bronchoscopy with Laser and Stent Placement for Bronchus Intermedius Obstruction from Lung Cancer Involving the Right Main Pulmonary Artery

image

This chapter emphasizes the following elements of the Four Box Approach: risk-benefit analyses and therapeutic alternatives; and anatomic dangers and other risks.

Case Description

A 50-year-old female with a 30–pack-year history of smoking developed wheezing and worsening shortness of breath, limiting her daily activities. Right lateral decubitus position worsened her symptoms, and she could not sleep on her right side. She was admitted to an outside hospital, where flexible bronchoscopy showed complete obstruction of the right upper lobe bronchus and severe obstruction (≈80%) of the bronchus intermedius (BI). She was transferred for bronchoscopic restoration of airway patency. The patient had a history of stage III squamous cell carcinoma of the lung diagnosed 18 months previously. Her pulmonary function test at that time showed a vital capacity of 2.94 L (80% predicted) and FEV1 of 2.39 L (85% predicted). She received neoadjuvant chemotherapy and radiation therapy followed by right lower lobectomy and mediastinal node dissection; all nodes were negative. The primary tumor measured 2.5 × 2 × 2 cm and extended to the parenchymal resection margins; evidence showed peritumoral lung consolidation related to the secondary effects of radiation therapy. Shortly after undergoing treatment, the patient lost her insurance coverage and was unable to pursue clinical or imaging surveillance. Comorbidities included rheumatoid arthritis (RA) requiring methotrexate and prednisone 20 mg/day and bipolar disorder treated with valproic acid. She was unemployed and divorced and lived with her children. Her physical examination was remarkable for expiratory wheezing noted in the right lung field. No limitation of cervical spine mobility was detected, but she had ulnar deviation of her hands and swan neck deformities of her fingers. She had significant functional impairment with a KPS score of 30 and was scored ECOG 3. Chest radiography showed a prominent hilar mass and right middle lobe atelectasis (Figure 22-1, A). Chest CT revealed a mass measuring 4 × 7 × 3 cm that invaded the BI and encased the right pulmonary artery (Figure 22-1, B). Repeat flexible bronchoscopy showed a near complete mixed pattern of obstruction (by exophytic tumor and extrinsic compression) of the BI, but right middle lobe bronchial segments were patent. The right upper lobe bronchus was occluded by extrinsic compression (Figure 22-1, C and D), but the flexible bronchoscope could be passed beyond the occluded airway, noting patent anterior and apical segmental bronchi (see video on ExpertConsult.com) (Video V.22.1image). Echocardiogram showed a systolic pulmonary artery pressure of 60 mm Hg and a moderately dilated right atrium but normal bilateral ventricular size and function.

Case Resolution

Initial Evaluations

Physical Examination, Complementary Tests, and Functional Status Assessment

This patient’s focal wheezing on auscultation of the right chest suggests airflow obstruction distal to the carina.1 Positional wheezing suggests a component of dynamic obstruction such as excessive dynamic airway collapse, malacia, or, as in our patient, positional worsening in an already narrowed airway. When localized to a bronchus, these processes will be worsened in the lateral decubitus position.

The hand-joint deformities seen in this patient are characteristic of advanced rheumatoid arthritis (RA) and may predict involvement of the axial skeleton,2 of which the cervical spine joints are the most clinically important, with a prevalence of involvement ranging from 15% to 86%.3 This patient had no symptoms of instability related to atlantoaxial (C1-C2) or subaxial (below C1-C2) subluxation. These include neck pain, stiffness, and radicular pain, all of which should be explored in cases of rigid bronchoscopy or endotracheal intubation. During these procedures, the cervical spine is hyperextended to align the mouth, larynx, and trachea. In one study, preoperative cervical spine assessment with cervical spine films in asymptomatic patients with RA before elective surgery revealed an incidence of unsuspected C1-C2 subluxation of 5.5%.4 Subluxations can vary over time, may be unrecognized, and can be fatal in up to 10% of patients because of spinal cord or brainstem compression.5 Because of the dangers of neck movements required for intubation, and because subluxation is not always symptomatic, radiographic evaluation of the cervical spine probably should be considered for all patients with RA scheduled to undergo procedures requiring cervical manipulation.6

The cricoarytenoid joint may be involved in 30% of patients with RA. Hoarseness and stridor in patients with RA suggest laryngeal involvement and are present in 75% of patients,7 but those with chronic cricoarytenoid arthritis may be relatively asymptomatic. Any disease process leading to hyperventilation, increased airflow (exertion, acidosis, infection), or reduction in the diameter of the airway (upper respiratory infection) can precipitate symptoms.8 In addition, patients with cricoarytenoid arthritis are at risk both during intubation and after extubation. Intubation may be difficult if the airway is narrow and, even if atraumatic and of short duration, can prompt mucosal edema and further compromise of airway caliber, leading to airway obstruction and stridor following extubation.9 Systemic glucocorticoids are often effective in reversing the obstruction caused by acute cricoarytenoid arthritis, and local periarticular steroid injections have been shown to improve cricoarytenoid function. In chronic cricoarytenoid arthritis, the degree of airflow limitation dictates the need for laser cordotomy or arytenoidectomy.10 Other potential manifestations of RA that could interfere with airway management include limited temporomandibular joint (TMJ) mobility (<4.5 cm), which is present in approximately 66% of patients with long-standing RA. Most of these patients experience pain and tenderness in the TMJ. Upper airway obstruction can occur because of pharyngeal obstruction, as in patients with micrognathia or obstructive sleep apnea. Furthermore, a small mouth opening from TMJ disease may preclude rigid bronchoscopic intubation. In our patient, upper airway anatomy was normal, and no signs of RA-related laryngeal involvement or TMJ disease were noted.

Comorbidities

This patient had been diagnosed with bipolar disorder. Although possibly attributable to higher unmeasured severity of illness in patients with psychiatric comorbidity, existing psychiatric disease has been found to be associated with a modestly increased risk of death among patients undergoing surgery.11 Our patient had been taking prednisone 20 mg/day for many years. The equivalent of 15 mg/day of prednisone for longer than 3 weeks should raise suspicion for hypothalamic-adrenal axis suppression,12 warranting increased glucocorticoid supplementation associated with possible adrenal insufficiency related to medical and surgical stress.12 In this regard, one must recall that supplemental corticosteroids can induce or exacerbate manic or depressive episodes, potentially interfering with postoperative care.13

Procedural Strategies

Expected Results

Relief of BI obstruction was expected to improve her lung function and potentially her dyspnea by restoring ventilation to the right middle lobe. A vast majority of patients with malignant central airway obstruction (CAO) improve their dyspnea and performance status if the CAO is palliated. The modality used to restore airway patency (i.e., laser, stent, photodynamic therapy [PDT], electrocautery, or brachytherapy) depends on tumor characteristics (i.e., extrinsic, endoluminal, or mixed) and severity and type of obstruction (i.e., critical, compromising respiratory status), operator preference, and availability of specific technologies.18 The modality used to restore airway patency might not make a difference in terms of outcome, suggesting that it is restoration of airway patency per se that counts, not the method used to achieve it.19 Survival may also be improved, especially if further systemic therapy can be initiated post procedure. Overall, the median survival of patients with untreated malignant CAO can be as low as 1 to 2 months.20 If interventional bronchoscopy is successful in relieving airway obstruction, survival is similar to that in patients without CAO.21 Stent insertion results in significant improvement in Medical Research Council Dyspnea Scales (MRC)-measured dyspnea and Eastern Cooperative Oncology Group (ECOG) performance status, although in one study, a significant survival advantage was seen only in the intermediate performance group (ECOG ≤3, MRC ≤4) when compared with historic controls. Perhaps improved survival is noted if airway patency is restored before the development of complications such as post obstructive pneumonia, irreversible atelectasis, or loss of ventilatory function from malignant CAO.22

Therapeutic Alternatives

External beam radiation therapy (EBRT) for recurrent locally advanced NCSLC previously treated with radiation therapy is a feasible, noninvasive therapeutic alternative.23 However, when associated severe airway obstruction results in atelectasis, the response rate is 20% to 50% in studies involving more than 50 patients.24 Smaller studies showed that bronchial obstruction could be relieved in up to 74% of patients, resulting in complete or partial re-expansion of the collapsed lung. The time to initiation of treatment matters because 71% of patients irradiated within 2 weeks after radiologic evidence of atelectasis had complete re-expansion of their lungs, compared with only 23% of those irradiated after 2 weeks.25 In our patient, EBRT was potentially limited by evidence of radiation-induced toxicity from previous radiotherapy. Improvements in imaging and treatment planning using three-dimensional (3D) conformational radiation and respiratory gating can precisely target radiotherapy, and by decreasing the normal tissue margins included to account for uncertainties in position, can diminish the risk of clinically significant pneumonitis and esophagitis.26

Endobronchial brachytherapy (EBB) has proven efficacy in patients with endoluminal tumor and a substantial extrabronchial component. For palliation of NSCLC symptoms, EBB alone appears to be less effective than EBRT. For this patient previously treated with EBRT, who was symptomatic from recurrent endobronchial CAO, EBB is a reasonable alternative.27 Success rates vary between 53% and 95%,28 but the overall incidence of fatal hemoptysis is 10% (range, 0% to 42%). Irradiation in the vicinity of major vessels, in this case the right pulmonary artery, increases bleeding risk.29 In fact some authors suggest that patients with tumors involving the major vessels should be excluded from EBB.30 Squamous cell pathology and tumor located in the mainstem bronchus or upper lobe represent additional risk factors for hemoptysis.31 Patients with poor performance status may be at higher risk for periprocedural complications such as cough, bronchospasm, and pneumothorax caused by catheter placement.

Photodynamic therapy (PDT) could be provided, but because of the severe nature of the airway obstruction, the sloughed tissue resulting from PDT could occlude the airway and cause complete obstruction, resulting in worsening symptoms and post obstructive pneumonia.32 This patient’s previous surgery, chemotherapy, and radiation therapy did not represent contraindications to PDT, and in fact this therapy can be offered to patients who become unresponsive to chemotherapy or radiation therapy.33 PDT is most effective when obstruction from mucosal disease is greater than 50% and in patients with good performance status.34

Buy Membership for Pulmolory and Respiratory Category to continue reading. Learn more here